Difference between revisions of "Nishitani S, et al. PLoS ONE (2013) cited as Ref 374 in DOI: 10.1038/s41392-020-0110-5 (Q9637)"
Jump to navigation
Jump to search
(Created claim: Page(s) (P105): e82346-, #quickstatements; #temporary_batch_1590074839150) |
(Created claim: Fourth Author string (P152): Yano H, #quickstatements; #temporary_batch_1590155310798) |
||
| Property / Fourth Author string | |||
| + | Yano H | ||
| Property / Fourth Author string: Yano H / rank | |||
| + | Normal rank | ||
Latest revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Nishitani S, et al. PLoS ONE (2013) cited as Ref 374 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Nishitani S
0 references
Horie M
0 references
Ishizaki S
0 references
2013
0 references
PLoS ONE
0 references
8
0 references
Branched chain amino acid suppresses hepatocellular cancer stem cells through the activation of mammalian target of rapamycin (English)
0 references
e82346-
0 references
Yano H
0 references
